News in brief

Colorcon and Applied DNA Sciences sign tech MOU

By Staff reporter

- Last updated on GMT

Gettyimages/grThirteen
Gettyimages/grThirteen

Related tags: Pharmacology, Science, Counterfeit

Colorcon Inc. and Applied DNA Sciences Inc. have teamed up to commercialize an on-dose traceability platform they say will help combat counterfeits.

The memorandum of understanding – which is expected to be followed by a definitive licensing deal – will see Colorcon integrate Applied DNA’s “molecular taggant” technology into its film coating, ink and colour dispersion systems.

Taggants are encoded materials that are impossible to duplicate.

Kelly Boyer, manager of film coating at Colorcon, said, “By incorporating molecular taggants from Applied DNA into our specialty excipients, Colorcon is able to offer a simple and seamless solution to our pharmaceutical and nutraceutical customers to address counterfeiting and product diversion issues​.”

According to Colorcon "This collaboration will commercialize a platform for traceability directly on dose, and is intended to significantly reduce the risks associated with counterfeit and falsified medications entering the drug supply chain.​"

Related news

Show more

Related products

show more

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Technical / White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Bio4C™ ProcessPad Software Datasheet

Bio4C™ ProcessPad Software Datasheet

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Data Sheet

Biopharmaceutical processes are complex and highly variable in nature. This can result in inconsistent and sometimes unpredictable process outcomes. To...

Related suppliers

Follow us

Products

View more

Webinars